BUZZA joins the board of Alcidion Corporation
(PRWEB) May 19, 2014 -- Buzza was well known for his CommtechWireless business, which developed clinical middleware solutions that were deployed globally. In 2008, Buzza divested CommtechWireless to Amcom Software, which was acquired by USA Mobility for $USD163.8m. Most recently, Buzza had announced his divestment of Azure Healthcare, a manufacturer of nursecall and clinical workflow solutions.
“I am extremely excited to be coming on board with Alcidion. After spending the last two decades in the clinical middleware space, I have had the opportunity to review countless software platforms and without a doubt, the Alcidion platform represents one of the most significant innovations in Clinical Decision Support that I have seen over this time.
The entire team at Alcidion should be commended on developing a world class solution and I am looking forward to commercializing the platform.
Alcidion’s VP Clinical Systems and co-founder, Professor Malcolm Pradhan holds a PhD from Stanford University in Medical Informatics and was recently the clinical lead for the National e-Health Transition Authority as is considered a global authority on Clinical Decision Support. Professional Pradhan commented “Health care will be unsustainable due to generational changes with a three to four times increase in complex patients – the only viable solution to develop a sustainable health care environment requires that health IT play an integral role in health care delivery.
Alcidion’s Chief Executive and co-founder, Mr Ray Blight, a former Chairman and CEO of the SA Health Commission, commented “Health care is primarily about risk management: Detection, monitoring and mitigation. An informatics platform should play a more active role in assisting clinicians. Over the past decade, Alcidion has invested millions of dollars into developing a world class solution and we extremely excited about commercializing the platform.”
ABOUT ALCIDON
Alcidion is an innovative health informatics company that specializes in clinical products that improve productivity, safety and efficiency.
Alcidion provides active intelligence and decision support software for high performance healthcare. By making clinicians more efficient, eliminating key clinical risks, tracking patient progress through journeys within and between healthcare facilities and making recommendations about patient care to the care team based on complex analysis of the clinical and administrative context for each patient, the patient flow, patient safety and organisational efficiency can all be improved and key critical risks eliminated.
Alcidion has created the Miya Platform, which uses a Decision Support Engine (DSE) to actively monitor electronic data feeds to detect emerging risk to patients and to the organization. Miya can provide guidance to the right people to mitigate risk before harm occurs.
Nathan Buzza, Allure Capital, http://www.allurecapital.com.au, +61 488862222, [email protected]
Share this article